⌘K
Loading ticker…
Briacell Therapeutics Corp. Common Shares · Healthcare · Pharmaceutical Products
As of 2026-06-26, Briacell Therapeutics Corp. Common Shares (BCTX) has a 3-month relative strength percentile of 16 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 32. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.2%, relative volume 0.51×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
16 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
BCTX is in a stage 4 downtrend, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -14.1% / -53.7%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BCTX Jan avg: -9.67% median: -34.55% win: 25% σ: 54.13% n: 4 2022-04-12 → 2026-05-29 | BCTX Feb avg: -14.86% median: -13.59% win: 0% σ: 9.13% n: 4 2022-04-12 → 2026-05-29 | BCTX Mar avg: -0.74% median: 2.34% win: 50% σ: 11.83% n: 4 2022-04-12 → 2026-05-29 | BCTX Apr avg: -8.54% median: -0.24% win: 20% σ: 24.20% n: 5 2022-04-12 → 2026-05-29 | BCTX May avg: -21.24% median: -22.12% win: 0% σ: 5.47% n: 5 2022-04-12 → 2026-05-29 | BCTX Jun avg: -5.91% median: -3.14% win: 50% σ: 21.82% n: 4 2022-04-12 → 2026-05-29 (current) | BCTX Jul avg: -22.94% median: -14.89% win: 50% σ: 39.99% n: 4 2022-04-12 → 2026-05-29 | BCTX Aug avg: 8.97% median: 6.07% win: 100% σ: 7.19% n: 4 2022-04-12 → 2026-05-29 | BCTX Sep avg: 14.57% median: 14.25% win: 50% σ: 41.29% n: 4 2022-04-12 → 2026-05-29 | BCTX Oct avg: -17.14% median: -17.07% win: 0% σ: 18.60% n: 4 2022-04-12 → 2026-05-29 | BCTX Nov avg: 7.84% median: 9.22% win: 50% σ: 17.56% n: 4 2022-04-12 → 2026-05-29 | BCTX Dec avg: -19.36% median: -22.78% win: 25% σ: 22.28% n: 4 2022-04-12 → 2026-05-29 |